Dr. Waleed M. Hussein currently works at the Institute for Molecular Bioscience, University of Queensland, Australia. He was awarded his PhD in Organic Chemistry from the School of Chemistry and Molecular Biosciences, University of Queensland, in 2010. He started a postdoctoral position (2010–2012) in the same school on a project targeting the design and synthesis of small inhibitor molecules against metallo-beta-lactamases and purple acid phosphatase. From 2012 to 2022, he worked with Prof. Toth's group on the development of gene delivery, peptide-based vaccines, and tropical disease immunity. In 2022, he moved to Prof. Capon's lab at the Institute for Molecular Bioscience, University of Queensland, to focus on the synthesis of bioactive molecules for the treatment of multiple diseases, such as inflammatory bowel disease (IBD), and antiparasitic applications, in addition to synthesizing natural products. He is also a Professor in the Pharmaceutical Organic Chemistry Department at the Faculty of Pharmacy, Helwan University, Egypt.